The Very Long COVID: Persistence of Symptoms after 12-18 Months from the Onset of Infection and Hospitalization.
COVID-19
long COVID
long follow-up
major neurological symptoms
major physical symptoms
persistent symptoms
post-acute
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
28 Feb 2023
28 Feb 2023
Historique:
received:
24
01
2023
revised:
20
02
2023
accepted:
24
02
2023
entrez:
11
3
2023
pubmed:
12
3
2023
medline:
12
3
2023
Statut:
epublish
Résumé
According to the World Health Organization's definition, long COVID is the persistence or development of new symptoms 3 months after the initial infection. Various conditions have been explored in studies with up to one-year follow-up but very few looked further. This prospective cohort study addresses the presence of a wide spectrum of symptoms in 121 patients hospitalized during the acute phase of COVID-19 infection, and the association between factors related to the acute phase of the disease and the presence of residual symptoms after one year or longer from hospitalization. The main results are as follows: (i) post-COVID symptoms persist in up to 60% of the patient population at a mean follow-up of 17 months; (ii) the most frequent symptoms are fatigue and dyspnea, but neuropsychological disturbances persist in about 30% of the patients (iii) when corrected for the duration of follow-up with a freedom-from-event analysis; only complete (2 doses) vaccination at the time of hospital admission remained independently associated with persistence of the major physical symptoms, while vaccination and previous neuropsychological symptoms remained independently associated with persistence of major neuropsychological symptoms.
Identifiants
pubmed: 36902702
pii: jcm12051915
doi: 10.3390/jcm12051915
pmc: PMC10003916
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Ministry of Health of Italy
ID : Not applicable
Références
J Med Virol. 2021 Feb;93(2):1013-1022
pubmed: 32729939
Front Med (Lausanne). 2022 Nov 11;9:1016013
pubmed: 36438042
PLoS One. 2022 Dec 30;17(12):e0279333
pubmed: 36583998
Front Immunol. 2022 Dec 19;13:1038227
pubmed: 36601115
Thorax. 2021 Apr;76(4):399-401
pubmed: 33273026
Nat Med. 2021 Apr;27(4):601-615
pubmed: 33753937
Respirology. 2022 Aug;27(8):605-616
pubmed: 35694728
J Infect. 2021 Mar;82(3):378-383
pubmed: 33450302
PLoS One. 2020 Dec 11;15(12):e0243882
pubmed: 33306721
Medicina (Kaunas). 2022 Dec 06;58(12):
pubmed: 36556998
Ann Intern Med. 2021 Apr;174(4):576-578
pubmed: 33175566
J Clin Med. 2022 Dec 14;11(24):
pubmed: 36556030
Int J Infect Dis. 2023 Jan;126:10-13
pubmed: 36375693
PLoS One. 2022 Dec 20;17(12):e0278825
pubmed: 36538532
J Infect. 2020 Dec;81(6):e4-e6
pubmed: 32853602
Respir Med Res. 2022 Nov 25;83:100976
pubmed: 36473331
Neuropsychology. 2023 Jan 05;:
pubmed: 36603126